C07C 233/16
Having the nitrogen atom of at least one of the carboxamide groups
Official title: having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
C07C233/16 (Having the nitrogen atom of at least one of the carboxamide groups) appears on 1,520 US grants and 1,220 published applications in this corpus.
Search patents in C07C- Granted patents
- 1,520
- Published applications
- 1,220
- Assignees
- 816
- Inventors
- 3,997
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 8 | 0 |
| 1977 | 11 | 0 |
| 1978 | 14 | 0 |
| 1979 | 9 | 0 |
| 1980 | 4 | 0 |
| 1981 | 8 | 0 |
| 1982 | 7 | 0 |
| 1983 | 2 | 0 |
| 1984 | 6 | 0 |
| 1985 | 8 | 0 |
| 1986 | 6 | 0 |
| 1987 | 8 | 0 |
| 1988 | 4 | 0 |
| 1989 | 6 | 0 |
| 1990 | 20 | 0 |
| 1991 | 25 | 0 |
| 1992 | 29 | 0 |
| 1993 | 32 | 0 |
| 1994 | 29 | 0 |
| 1995 | 29 | 0 |
| 1996 | 70 | 0 |
| 1997 | 74 | 0 |
| 1998 | 66 | 0 |
| 1999 | 50 | 0 |
| 2000 | 43 | 0 |
| 2001 | 44 | 10 |
| 2002 | 46 | 38 |
| 2003 | 35 | 50 |
| 2004 | 43 | 61 |
| 2005 | 22 | 53 |
| 2006 | 32 | 49 |
| 2007 | 41 | 55 |
| 2008 | 35 | 58 |
| 2009 | 39 | 47 |
| 2010 | 39 | 57 |
| 2011 | 30 | 45 |
| 2012 | 42 | 45 |
| 2013 | 26 | 47 |
| 2014 | 53 | 64 |
| 2015 | 42 | 61 |
| 2016 | 53 | 57 |
| 2017 | 42 | 60 |
| 2018 | 35 | 41 |
| 2019 | 35 | 47 |
| 2020 | 40 | 53 |
| 2021 | 40 | 42 |
| 2022 | 34 | 34 |
| 2023 | 30 | 52 |
| 2024 | 35 | 27 |
| 2025 | 20 | 38 |
| 2026 | 19 | 29 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Acrylate derivatives and uses thereof25 Aug 2026US 12,716,086 B2Expansion Technologies
- Tricine and citric acid lipids4 Aug 2026US 12,697,302 B2Translate Bio, Inc.
- Crystalline solids of 3-palmitoyl-amido-1,2-propanediol and 3-palmitoyl-amido-2-hydroxy-1-dimethoxytriphenylmethylether-propane and methods of making and using the same4 Aug 2026US 12,698,254 B2Geron Corporation
- Branched type hetero monodispersed polyethylene glycol, production method thereof, and conjugate thereof7 Jul 2026US 12,674,025 B2Nof Corporation
- Lipids and lipid nanoparticle formulations for delivery of nucleic acids30 Jun 2026US 12,667,627 B2Acuitas Therapeutics, Inc.
- Novel carboxamide derivatives8 Oct 2026US 2026/0308149 A1Angelini Pharma S.P.A.
- Crystalline form of ceramide np and composition including the same24 Sep 2026US 2026/0283927 A1Croda Korea Ltd
- Camelid-Derived Bioactive Compounds: Compositions, Methods, and Therapeutic Analgesic Applications17 Sep 2026US 2026/0272992 A1Applied Bio Research Inc.
- Method for quantitatively analyzing polysulfide in sample27 Aug 2026US 2026/0250239 A1Bio-Xcelerator, Inc.
- Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium27 Aug 2026US 2026/0250591 A1Resonac Corporation
Most cited
By later US patents
- Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof277US 5,549,974 AAffymax Technologies N.V. · 1996
- Non-nucleoside linkers for convenient attachment of labels to oligonucleotides using standard synthetic methods234US 5,414,077 AGilead Sciences, Inc. · 1995
- UV curable crosslinking agents useful in copolymerization224US 5,449,729 ABausch & Lomb Incorporated · 1995
- Polyethyleneglycol-modified lipid compounds and uses thereof224US 7,803,397 B2Protiva Biotherapeutics, Inc. · 2010
- UV curable crosslinking agents useful in copolymerization217US 5,310,779 ABausch & Lomb Incorporated · 1994